Risk of endometrial cancer in relation to medical conditions and medication use

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 5, 2009, Pages 1448-1456

  Fortuny, Joan ^a   Sima, Camelia ^b   Bayuga, Sharon ^b   Wilcox, Homer ^c   Pulick, Katherine ^d   Faulkner, Shameka ^e   Zauber, Ann G ^b   Olson, Sara H ^b  

^a CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c NEW JERSEY DEPARTMENT OF HEALTH AND SENIOR SERVICES   (United States)

^d WEILL CORNELL MEDICAL CENTER   (United States)

^e Glencoe/McGraw Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ATENOLOL; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BEZAFIBRATE; BIGUANIDE DERIVATIVE; BISOPROLOL; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; GLIBENCLAMIDE; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDAPAMIDE; INSULIN; METFORMIN; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM SPARING DIURETIC AGENT; RAMIPRIL; REPAGLINIDE; SIMVASTATIN; SULFONYLUREA DERIVATIVE; TELMISARTAN; THIAZIDE DIURETIC AGENT; UNINDEXED DRUG; VERAPAMIL;

ADULT; AGED; ANEMIA; ARTICLE; CANCER RISK; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OSTEOPOROSIS; PRIORITY JOURNAL; RISK FACTOR; UNITED STATES; UTERUS MYOMA;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-OBESITY AGENTS; CALCITONIN; CASE-CONTROL STUDIES; DIPHOSPHONATES; DIURETICS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYPERTENSION; INTERVIEWS AS TOPIC; LOGISTIC MODELS; MIDDLE AGED; OBESITY; OSTEOPOROSIS; RISK FACTORS; UNITED STATES;

EID: 66549105717     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0936     Document Type: Article

References (37)

1. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000: Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5, version 2.0 IARCPress, Lyon, 2004.
2. Modugno F, Ness RB, Chen C, Weiss NS. Inflammation and endometrial cancer. Cancer Epidemiol Biomarkers Prev 2005;14:2840-2847
3. Vaskivuo TE, Stenback F, Tapanainen JS. Apoptosis and apoptosis related factors Bcl-2, Bax, tumor necrosis factor-á, and NF-κb in human endometrial hyperplasia and carcinoma. Cancer 2002;95:1463-1471
4. Cao QJ, Einstein MH, Anderson PS, Runowicz CD, Balan R, Jones JG. The expression of cyclooxigenase-1 and -2 in proliferative endometrium and endometrial carcinoma. Int J Gynecol Pathol 2002;21:147-154 (Pubitemid 34260635)
5. Jeon YT, Kang S, Kang DH. Cyclooxygenase-2 and p53 expressions in endometrial cancer. Cancer Epidemiol Biomarkers Prev 2004;13:1538-1542 (Pubitemid 39202324)
6. Furberg AS, Thune I. Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort. Int J Cancer 2003;104:669-676 (Pubitemid 36418502)
7. Weiderpass E, Persson I, Adami HO, Magnusson C. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control 2000;11:185-192 (Pubitemid 30088399)
8. Soler M, Chatenoud L, Negri E, Parazzini F, Franceschi S, La Vecchia C. Hypertension and hormone-related neoplasms in women. Hypertension 1999;34:320-325
9. Moysich KB, Baker JA, Rodabaugh KJ, Villella JA. Regular analgesic use and risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev 2005;14:2923-2928 (Pubitemid 43068826)
10. Viswanathan AN, Feskanich D, Schernhammer ES, Hankinson SE. Aspirin, NSAID, and acetaminophen use and the risk of endometrial cancer. Cancer Res 2008;68:2507-2513
11. Harrell FE. Regression modeling strategies with applications to linear models, logistic regression, and survival analysis. New York: Springer; 2001.
12. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
13. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. 2007. Report No. 2.
14. Saltzman BS, Doherty JA, Hill DA, et al. Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors. Am J Epidemiol 2007;167:607-614
15. Friberg E, Orsini N, Mantzoros CS, Wolk A. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 2007;50:1365-1374 (Pubitemid 46879010)
16. Persson I, Naessén T, Adami HO, etal. Reduced risk of hip fracture in women with endometrial cancer. Int J Epidemiol 1992;21:636-642
17. Persson I, Adami HO, McLaughlin JK, Naessén T, Fraumeni JF, Jr. Reduced risk of breastand endometrial cancer among women with hip fractures (Sweden). Cancer Causes Control 1994;5:523-528
18. Newcomb PA, Trentham-Dietz A, Egan KM, et al. Fracture history and risk of breastand endometrial cancer. Am J Epidemiol 2001;153:1071-1078 (Pubitemid 32493255)
19. Brinton LA, Sakoda LC, Frederiksen K, et al. Relationships of uterine and ovarian tumors to pre-existing chronic conditions. Gynecol Oncol 2007;107:487-494 (Pubitemid 350160860)
20. Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol 1990;94:435-438 (Pubitemid 20316570)
21. Weitzmann MN, Pacifici R. Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest 2006;116:1186-1194
22. Ross RK, Pike MC, Vessey MP, Bull D, Yeates D, Casagrande JT. Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Br Med J 1986;293:359-362 (Pubitemid 16034122)
23. Potischman N, Hoover RB, Brinton LA, et al. Case-control study of endogenous steroid hormones and endometrial cancer. J Natl Cancer Inst 1996;88:1127-1135 (Pubitemid 26274607)
24. Bucher JR, Huff J, Haseman SL, etal. Toxicology and carcinogenicity studies of diuretics in F344 rats and B6C3F1 mice. 1. Hydrochlorothiazide. J Appl Toxicol 1990;10:359-367 (Pubitemid 20324712)
25. Sowers JR, Bakris GL. Antihypertensive therapy and the risk of type 2 diabetes mellitus. N Eng J Med 2000;342:969-970 (Pubitemid 30177059)
26. Gress TW, Nieto J, Shahar E, Wofford MR, Brancati FL. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. N Eng J Med 2000;342:905-912 (Pubitemid 30177050)
27. Padwal R, Mamdani M, Alter DA, et al. Antihypertensive therapy and incidence of type 2 diabetes in an elderly cohort. Diabetes Care 2004;27:2458-2463 (Pubitemid 39281401)
28. Rejnmark L, Vestergaard P, Mosekilde L. Reduced fracture risk in users of thiazide diuretics. Calcif Tissue Int 2005;76:167-175 (Pubitemid 41557145)
29. Sowers MR, Clark MK, Jannausch ML, Wallace RB. Body size, estrogen use and thiazide diuretic use affect 5-year radial bone loss in postmenopausal women. Osteoporos Int 1993;3:314-321 (Pubitemid 23344048)
30. Lekander I, Borgström F, Tröm O, Ethraeus N, Kanis JA. Cost effectiveness of hormone therapy in women at high risks of fracture in Sweden, the US and the UK-results based on the Women's Health Initiative randomised controlled trial. Bone 2008;42:294-306.
31. August P. Initial treatment of hypertension. N Eng J Med 2003;348:610-617 (Pubitemid 36204956)
32. Hudson AG, Gierach GL, Modugno F, etal. Nonsteroidal antiinflammatory drug use and serum total estradiol in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2008;17:680-687
33. Schoff SM, Newcomb PA. Diabetes, body size, and risk of endometrial cancer. Am J Epidemiol 1998;148:234-240 (Pubitemid 28355341)
34. Anderson KE, Anderson E, Mink PJ, etal. Diabetes and endometrial cancer in the Iowa Health Study. Cancer Epidemiol Biomarkers Prev 2001;10:611-616
35. Global Behavioural Risk Factor Surveillance. New York: Kluwer Academic/Plenum Publishers; 2005.
36. Leitzmann MF, Tsai CJ, Stampfer MJ, Willett WC, Giovannucci E. Thiazide diuretics and the risk of gallbladder disease requiring surgery in women. Arch Intern Med 2005;165:567-573 (Pubitemid 40344390)
37. Kirsh VA, Kreiger N, Cotterchio M, Sloan M, Theis B. Nonsteroidal antiinflammatory drug use and breast cancer risk: subgroup findings. Am J Epidemiol 2007;166:709-716 (Pubitemid 47347905)